Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Special Report
  • Published:

Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT)

Bone Marrow Transplantation volume 29, pages 191–195 (2002)Cite this article

Abstract

A second meeting on reduced intensity allogeneic stem cell transplants (RI-HSCT) was convened in Zurich in February 2001 and focused on transplant-related mortality (TRM) and graft-versus-host disease (GVHD). Retrospective and prospective studies from the EBMT, national groups and single institutions included over 900 patients: the incidence of acute GVHD grade III–IV was 12% (1–17%), extensive chronic GVHD 42% (25–51%) and TRM 20% (14–38%). Conditioning regimens could be classified into four major groups based on (1) total body irradiation (TBI) 200 cGy, (2) busulfan 8 mg/kg, (3) thiotepa 10 mg/kg, and (4) melphalan 140 mg/m2: most of these regimens are given in association with fludarabine in different doses and use mobilized peripheral blood as a source of stem cells. The incidence of TRM is similar if not identical for all four regimens, whereas the risk of acute GVHD and chronic GVHD may vary with different protocols. Reduced intensity transplant programs are being explored in patients above the age of 60 and in patients with solid tumors: encouraging results are being recorded in individual patients. Overall these data confirm that allogeneic HSCT can be performed in elderly patients, although a TRM of approximately 15% must be expected and is age dependent. A high rate of extensive chronic GVHD is seen and should be followed carefully. The term mini- or micro-transplant is probably misleading and one should refer to this procedure as an allogeneic HSCT and further classify the intensity of the conditioning regimen.

Bone Marrow Transplantation (2002) 29, 191–195 doi:10.1038/sj.bmt.1703355

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bacigalupo A . Hematopoietic stem cell transplants after reduced intensity conditioning regimen (RI-HSCT): report of a workshop of the European Group for Blood and Marrow Transplantation (EBMT) Bone Marrow Transplant 2000 25: 803 805

    Article  CAS  Google Scholar 

  2. Khouri IF, Keating M, Korbling M et al. Transplant lite: induction of graft versus malignancy using fludarabine based non ablative chemotherapy and allogeneic blood progenitor cell transplantation as treatment for lymphoid malignances J Clin Oncol 1998 16: 2817 2824

    Article  CAS  Google Scholar 

  3. Storb R, Yu C, Sanmeier BM et al. Mixed hemopoietic chimerism after marrow allografts. Transplantation in the ambulatory care setting Ann NY Acad Sci 1999 872: 372 375

    Article  CAS  Google Scholar 

  4. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Blood 1998 91: 756 763

    CAS  Google Scholar 

  5. Aversa F, Tabilio A, Terenzi A et al. Successful engraftment of T-cell-depleted haploidentical ‘three-loci’ incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum Blood 1994 84: 3948 3955

    CAS  Google Scholar 

  6. Aversa F, Tabilio A, Velardi A et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype New Engl J Med 1998 339: 1186 1193

    Article  CAS  Google Scholar 

  7. Bacigalupo A, van Lint MT, Valbonesi M et al. Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia Blood 1996 88: 353 357

    CAS  Google Scholar 

  8. Raiola AM, van Lint MT, Lamparelli T et al. Reduced intensity thiotepa–cyclophosphamide conditioning for allogeneic hemopoietic stem cell transplants (HSCT) in patients up to 60 years of age Br J Haematol 2000 109: 716 721

    Article  CAS  Google Scholar 

  9. Busca A, Bosi A, van Lint MT et al. Transplant-related mortality (TRM) in patients receiving reduced versus conventional intensity thiotepa–cyclophosphamide (THIO-CY) conditioning: the impact of stem cell source in 176 consecutive patients allografted from HLA-identical siblings Bone Marrow Transplant 2001 27: S282

    Article  Google Scholar 

  10. Corradini P, Bregni M, Tarella C et al. Allografting for high-risk hematological and solid tumors: reduced intensity chemotherapy followed by the reinfusion of lymphocytes engineered with thymidine kinase (TK) gene Bone Marrow Transplant 2000 25: S134

    Google Scholar 

  11. Kottaridis PD, Chakraverty R, Milligan DW et al. A non-myeloablative regimen for allogeneic stem cell transplantation with a low incidence of GVHD Bone Marrow Transplant 2000 25: S26

    Article  Google Scholar 

  12. Uberti J, Ayash L, Reynolds C et al. Lower intensity of preparative regimen for allogeneic stem cell transplantation from related donor in patients with advanced hematologic malignancy is associated with poor outcome Blood 2000 96: 201a (Abstr.)

    Google Scholar 

  13. Nagler A, Aker M, Or R et al. Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation Exp Hematol 2001 29: 362 370

    Article  CAS  Google Scholar 

  14. Lazarus H, Curtin P, Devine S et al. Role of mesenchymal stem cells (MSC) in allogeneic transplantation: early phase I clinical results Blood 2000 96: 392a (Abstr.)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisione Ematologia II Ospedale San Martino, Genova, Italy

    A Bacigalupo

Authors
  1. A Bacigalupo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bacigalupo, A. Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT). Bone Marrow Transplant 29, 191–195 (2002). https://doi.org/10.1038/sj.bmt.1703355

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703355

Keywords

This article is cited by

Search

Advanced search

Quick links